Vijoice (alpelisib) has been granted accelerated approval for severe PIK3CA-related overgrowth spectrum (PROS), the U.S. Food and Drug Administration announced April 6.
Apr 19, 2022
0
2
Despite months of intense lobbying by patient advocates, federal health officials on Monday posted a largely negative review of an experimental drug for amyotrophic lateral sclerosis (ALS).
Mar 30, 2022
0
14
If applied to the $5-billion-per-year dietary supplement industry, "quality by design" (QbD)—a mindset that helped revolutionize the manufacture of cars and hundreds of other products—could ease concerns about the safety ...
Oct 3, 2012
0
0
(AP)—The U.S. Food and Drug Administration says it has approved a first-of-a-kind heart-zapping implant from Boston Scientific that that does not directly touch the heart.
Sep 29, 2012
0
0
Of the 198 new oncology drugs approved by the U.S. Food and Drug Administration (FDA) between 1998 and 2022, approximately 43% were precision oncology therapies, the use of which is guided by biomarker testing.
Oct 18, 2023
0
0
The Food and Drug Administration (FDA) approved Narcan, 4 milligram (mg) nasal spray for over-the-counter sale. Narcan is a nasal spray version of naloxone, a rescue medicine that can be administered in the event of an opioid ...
Mar 30, 2023
0
2
A new prescription head lice treatment, developed by University of Melbourne Associate Professor Vern Bowles, has been given Food and Drug Administration (FDA) approval, allowing it to be sold in the U.S..
Aug 4, 2020
1
3
Antidepressants can play a key role in alleviating painful conditions like osteoarthritis and may result in fewer side effects than traditionally prescribed drug regimes, such as anti-inflammatories and opioids, according ...
Mar 22, 2012
0
0
A team of researchers led by Dr. Goutham Narla at Case Western Reserve University School of Medicine in collaboration with scientists at Mount Sinai School of Medicine in New York, have discovered a previously unrecognized ...
Jun 1, 2012
0
0
Biogen Inc. said Tuesday it will seek federal approval for a medicine to treat early Alzheimer's disease, a landmark step toward finding a treatment that can alter the course of the most common form of dementia.
Oct 22, 2019
0
7
